EGFR and breast cancer: Both of these BL breast cancer cell lines demonstrate over-expression of ErbB1 [30], [46] suggesting that ErbB1 may hetero-dimerize with low levels of endogenous ErbB2 (forming an ErbB1/ErbB2/EphrinB1 complex) and mediate signaling from the complex.